Iris Fontana
Overview
Explore the profile of Iris Fontana including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
150
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cioni M, Muscianisi S, De Cicco M, Basso S, Hirsch H, Fontana I, et al.
Microorganisms
. 2025 Jan;
13(1).
PMID: 39858816
Polyomavirus BK (BKPyV)-associated nephropathy (BKPyV-nephropathy) remains a significant cause of premature kidney allograft failure. In the absence of effective antiviral treatments, current therapeutic approaches rely on immunosuppression (IS) reduction, possibly...
2.
Comoli P, Cioni M, Ray B, Tagliamacco A, Innocente A, Caridi G, et al.
Front Med (Lausanne)
. 2022 Dec;
9:1035400.
PMID: 36530923
Introduction: Immunity to Human leukocyte antigen (HLA) cannot explain all cases of ABMR, nor the differences observed in the outcome of kidney recipients with circulating DSAs endowed with similar biologic...
3.
Varotti G, Dodi F, Paoletti E, Bruno A, Fontana I
Case Rep Transplant
. 2021 Dec;
2021:1948560.
PMID: 34931152
. Hepatitis C virus (HCV) infection continues to represent a poor prognostic factor in kidney transplant (KTx) patients. New direct-acting antiviral agents (DAA) have dramatically changed the therapy management for...
4.
Vaisitti T, Peritore D, Magistroni P, Ricci A, Lombardini L, Gringeri E, et al.
Orphanet J Rare Dis
. 2021 Sep;
16(1):374.
PMID: 34481500
Background: Rare diseases are chronic and life-threatening disorders affecting < 1 person every 2,000. For most of them, clinical symptoms and signs can be observed at birth or childhood. Approximately...
5.
Cioni M, Comoli P, Tagliamacco A, Innocente A, Basso S, Fontana I, et al.
Transpl Immunol
. 2021 Feb;
65:101375.
PMID: 33610675
While de novo donor-specific HLA antibodies (dnDSAs) have a detrimental impact on kidney graft outcome, the clinical significance of de novo non donor-specific antibodies (dnNDSAs) is more controversial. We retrospectively...
6.
Varotti G, Atzori G, Bianchi V, Bruno A, Massimo Bertocchi , Pierpaolo Cupo , et al.
Am J Surg
. 2020 Dec;
221(5):913-917.
PMID: 33256942
No abstract available.
7.
Varotti G, Bianchi V, Fontana I
Urology
. 2020 Aug;
146:e12-e13.
PMID: 32827537
Kidneys with more than 3 arteries are very rare and decision to use or not these organs can be difficult, because there is an increased risk of post-transplant vascular complications,...
8.
Varotti G, Dodi F, Garibotto G, Fontana I
Transpl Int
. 2020 Jul;
33(10):1333-1334.
PMID: 32706459
No abstract available.
9.
Bussalino E, Marsano L, Parodi A, Russo R, Massarino F, Ravera M, et al.
J Nephrol
. 2020 Jun;
34(2):531-538.
PMID: 32533451
There is no specific therapy for polyoma BK virus nephropathy (BKVN) in kidney transplant recipients, a condition associated with poor outcomes. Everolimus showed promising antiviral effects, but data from prospective...
10.
Varotti G, Dodi F, Boscaneanu A, Terulla A, Sambuceti V, Fontana I
Transpl Infect Dis
. 2019 Sep;
21(6):e13183.
PMID: 31563146
Kidney transplantation is the gold-standard therapy for select HIV-positive patients with ESRD. Since the Italian Ministry of Health defined the guidelines for organ donation from HIV-positive persons in 2018, we...